Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04158921 · ClinicalTrials.gov registry record · NA
Control:Diabetes Pilot Study I
A NA study, sponsored by Brigham and Women's Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT04158921 is a NA study that was terminated before completion, run by Brigham and Women's Hospital. The registered enrollment target is 55 participants.
The verdict
NCT04158921, a NA study, was terminated before completion, sponsored by Brigham and Women's Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
This is a single arm open label pilot clinical trial that will assess patient-reported blood glucose levels before and after using the Control:Diabetes mobile app, while collecting user feedback and recommendations for further improvements to the app functionality and user interface. This study will enroll approximately 70 individuals with insulin-treated diabetes mellitus. The study will include two online surveys (baseline and exit), one study initiation phone call, and will also collect data entered by the users into the mobile app.
Interventions
- OTHER Control:Diabetes mobile app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2019-11-07 |
| Est. Completion | 2022-07-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04158921
The ClinicalTrials.gov registry entry for NCT04158921 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Control:Diabetes mobile app is the first listed.
NCT04158921 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04158921 about?
NCT04158921 is a clinical study titled "Control:Diabetes Pilot Study I". This is a single arm open label pilot clinical trial that will assess patient-reported blood glucose levels before and after using the Control:Diabetes mobile app, while collecting user feedback and recommendations for further improvements to the app functionality and user interface. This study will...
What is the current status of trial NCT04158921?
This trial is currently terminated. It is a NA study. The enrollment target is 55 participants. The study started on 2019-11-07. Estimated completion is 2022-07-20.
What interventions are being tested in trial NCT04158921?
The interventions under investigation include: Control:Diabetes mobile app (OTHER).
Who is sponsoring clinical trial NCT04158921?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.